X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
U.S. District Judge Denise L. Cote wrote that the one-time “Pharma Bro” violated state and federal laws in exerting monopoly power over Daraprim, which is used to treat parasitic infections and HIV. (Photo: Diego M. Radzinschi/ALM)

A New York federal judge on Friday ordered Martin Shkreli to pay nearly $65 million and banned the disgraced former executive from ever working in the pharmaceutical industry again, siding with Attorney General Letitia James in a high-profile lawsuit stemming from his move to dramatically raise the price of a life-saving drug in 2015.

U.S. District Judge Denise L. Cote said in a 135-page opinion that Shkreli, whose exploits once gave him the derogatory moniker “Pharma Bro,” violated state and federal laws in exerting monopoly power over Daraprim, which is used to treat parasitic infections and HIV.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2022 ALM Global, LLC. All Rights Reserved.